In contrast, both Rilmenidine-treated groups showed reduced TNF-α levels: diabetes + 0.1 mg/kg Rilmenidine group (33.1 ± 0.9 pg/mg), and diabetes + 0.2 mg/kg Rilmenidine group (30.3 ± 0.5 pg/mg). This evidence concerns the gene TNF and diabetes mellitus.